Pretreatment with bone marrowderived mesenchymal stromal cellconditioned media

Pretreatment with bone marrow–derived mesenchymal stromal cell–conditioned media confers pulmonary ischemic tolerance Billanna Hwang, MPH, W. Conrad Liles, MD, Ph. D, Rachel Waworuntu, BS, Michael S. Mulligan, MD The Journal of Thoracic and Cardiovascular Surgery Volume 151 Issue 3 Pages 841 -849 (March 2016) DOI: 10. 1016/j. jtcvs. 2015. 11. 043 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 The Journal of Thoracic and Cardiovascular Surgery 2016 151841 -849 DOI: (10. 1016/j. jtcvs. 2015. 11. 043) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 The Journal of Thoracic and Cardiovascular Surgery 2016 151841 -849 DOI: (10. 1016/j. jtcvs. 2015. 11. 043) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 The Journal of Thoracic and Cardiovascular Surgery 2016 151841 -849 DOI: (10. 1016/j. jtcvs. 2015. 11. 043) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 The Journal of Thoracic and Cardiovascular Surgery 2016 151841 -849 DOI: (10. 1016/j. jtcvs. 2015. 11. 043) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

The Journal of Thoracic and Cardiovascular Surgery 2016 151841 -849 DOI: (10. 1016/j. jtcvs. 2015. 11. 043) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions